Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Less pushing during labor may be safer for babies

NCT ID NCT03018860

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at two ways of managing the pushing stage of labor in first-time mothers with epidurals. One group was encouraged to push only twice per contraction (moderate), while the other pushed three times (intensive). The goal was to see if moderate pushing leads to better outcomes for newborns and mothers, such as fewer injuries or complications. Over 1,700 women took part across multiple hospitals in France.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could change standard labor practices to reduce stress on newborns and mothers without increasing complications.
What could go wrong
The trial is completed but results may not apply to all women (only first-time mothers with epidurals). The difference between groups might be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,701 people

The number who actually took part.

Started

Jan 2017

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * primiparous women * singleton fetus * fetal cephalic presentation * ≥37 gestational weeks * living fetus * Patient with epidural analgesia * Major Female * Women understand French Exclusion Criteria : * Abnormal fetal heart rate requiring hastening childbirth * cervical dilatation \< 8 cm * intrauterine fetal growth restriction \<5e percentile, * Fetal malformation, * history of gynecological surgery with uterine scar * Women do not understand French, * women with psychiatric condition * contraindication to intensive management of active second stage (severe myopia, respiratory or cardiac failure) * no affiliation to a social security scheme (beneficiary or assignee)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Active second stage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cochin Hospital

    Paris, Paris, 75014, France